OCGN Q4 2025 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$193,000-125.3% YoY

Gross Profit

-$3M1337.8% margin

Operating Income

-$17M8805.7% margin

Net Income

-$18M9174.1% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-111.0%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$44M

Total Liabilities

$56M

Stockholders' Equity

-$12M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$193,000	$764,000	-125.3%
Gross Profit	-$3M	$764,000	-438.0%
Operating Income	-$17M	-$14M	-22.8%
Net Income	-$18M	-$14M	-27.6%